Literature DB >> 9361723

Hepatic damage during acute pancreatitis in the rat.

A M Coelho1, M C Machado, S N Sampietre, K R Leite, V L Oliveira, H W Pinotti.   

Abstract

We studied the alterations in the metabolism of liver mitochondria in rats with acute pancreatitis. Male Wistar rats were allocated to a control group (group I) and to five other groups corresponding to 2, 4, 12, 24 and 48 h after the induction of acute pancreatitis by the injection of 5% sodium taurocholate into the pancreatic duct. Sham-operated animals were submitted to the same surgical steps except for the induction of acute pancreatitis. Mitochondrial oxidation and phosphorylation were measured polarographically by determining oxygen consumption without ADP (basal respiration, state 4) and in the presence of ADP (activated respiration, state 3). Serum amylase, transaminases (ALT and AST) and protein were also determined. Ascitic fluid, contents of amylase, trypsin and total protein were also determined and arterial blood pressure was measured in all groups. In ascitic fluid, trypsin and amylase increased reaching a maximum at 2 and 4 h, respectively. Serum amylase increased at 2 h reaching a maximum at 4 h. Serum transaminase levels increased at 12 and 24 h. After 2 h (and also 4 h) there was an increase in state 4 respiration (45.65 +/- 1.79 vs 28.96 +/- 1.50) and a decrease in respiration control rate (3.53 +/- 0.09 vs 4.45 +/- 0.08) and in the ADP/O ratio (1.77 +/- 0.02 vs 1.91 +/- 0.01) compared to controls (P < 0.05). These results indicate a disruption of mitochondrial function, which recovered after 12 h. In the 48-h groups there was mitochondrial damage similar to that occurring in ischemic lesion. Beat-to-beat analysis (30 min) showed that arterial blood pressure remained normal up to 24 h (111 +/- 3 mmHg) while a significant decrease occurred in the 48-h group (91 +/- 4 mmHg). These data suggest biphasic damage in mitochondrial function in acute pancreatitis: an initial uncoupled phase, possibly secondary to enzyme activity, followed by a temporary recovery and then a late and final dysfunction, associated with arterial hypotension, possibly related to ischemic damage.

Entities:  

Mesh:

Year:  1997        PMID: 9361723     DOI: 10.1590/s0100-879x1997000800006

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

1.  Early organ-specific mitochondrial dysfunction of jejunum and lung found in rats with experimental acute pancreatitis.

Authors:  Anubhav Mittal; Anthony J R Hickey; Chau C Chai; Benjamin P T Loveday; Nichola Thompson; Anna Dare; Brett Delahunt; Garth J S Cooper; John A Windsor; Anthony R J Phillips
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

2.  Ischemic preconditioning-like effect of polyunsaturated fatty acid-rich diet on hepatic ischemia/reperfusion injury.

Authors:  Ana Maria Mendonça Coelho; Marcel Cerqueira Cesar Machado; Hilton Kenji Takahashi; Sandra N Sampietre; José Tadeu Stefano; Andre Zonetti A Leite; Rui Curi; Luiz A Carneiro D'Albuquerque
Journal:  J Gastrointest Surg       Date:  2011-08-09       Impact factor: 3.452

3.  Beneficial effects of adenosine triphosphate-sensitive K+ channel opener on liver ischemia/reperfusion injury.

Authors:  Mateus Antunes Nogueira; Ana Maria Mendonça Coelho; Sandra Nassa Sampietre; Rosely Antunes Patzina; Fabiano Pinheiro da Silva; Luiz Augusto Carneiro D'Albuquerque; Marcel Cerqueira Cesar Machado
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion.

Authors:  Enio Rodrigues Vasques; Jose Eduardo Monteiro Cunha; Ana Maria Mendonca Coelho; Sandra N Sampietre; Rosely Antunes Patzina; Emilio Elias Abdo; Helena B Nader; Ivarne L S Tersariol; Marcelo Andrade Lima; Carlos M G Godoy; Tiago Rodrigues; Eleazar Chaib; Luiz A C D'Albuquerque
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.